Study identifier:SA-NXY-0009
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Interaction between NXY-059 and furosemide? A PK/PD study of intravenous doses of the two drugs to healthy volunteers.
Stroke
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|